tiprankstipranks
Relmada Therapeutics Inc (RLMD)
NASDAQ:RLMD
US Market
Want to see RLMD full AI Analyst Report?

Relmada Therapeutics (RLMD) Technical Analysis

445 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Relmada Therapeutics Inc’s (RLMD) Moving Averages Convergence Divergence (MACD) indicator is -0.35, suggesting Relmada Therapeutics Inc is a Buy.
Relmada Therapeutics Inc’s (RLMD) 20-Day exponential moving average is 5.25, while Relmada Therapeutics Inc’s (RLMD) share price is $5.18, making it a Sell.
Relmada Therapeutics Inc’s (RLMD) 50-Day exponential moving average is 5.77, while Relmada Therapeutics Inc’s (RLMD) share price is $5.18, making it a Sell.

Relmada Therapeutics (RLMD) Pivot Points

Aug 13, 2026, 11:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.06
4.20
4.34
4.48
4.62
4.76
4.90
Fibonacci
4.20
4.31
4.38
4.48
4.59
4.66
4.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relmada Therapeutics (RLMD) Moving Averages

Aug 13, 2026, 11:20 PM
Period
Simple
Exponential
MA5
4.81Sell
4.79Sell
MA10
5.09Sell
4.97Sell
MA20
5.14Sell
5.25Sell
MA50
5.93Sell
5.77Sell
MA100
6.51Sell
5.84Sell
MA200
5.33Sell
4.87Sell
Relmada Therapeutics Inc’s (RLMD) 10-Day exponential moving average is 4.97, while Relmada Therapeutics Inc’s (RLMD) share price is $5.18, making it a Sell.
Relmada Therapeutics Inc’s (RLMD) 100-Day exponential moving average is 5.84, while Relmada Therapeutics Inc’s (RLMD) share price is $5.18, making it a Sell.
Relmada Therapeutics Inc’s (RLMD) stock price is $5.18 and Relmada Therapeutics Inc’s (RLMD) 50-day simple moving average is 5.93, creating a Sell signal.
Relmada Therapeutics Inc’s (RLMD) stock price is $5.18 and Relmada Therapeutics Inc’s (RLMD) 100-day simple moving average is 6.51, creating a Sell signal.
Relmada Therapeutics Inc’s (RLMD) stock price is $5.18 and Relmada Therapeutics Inc’s (RLMD) 200-day simple moving average is 5.33, creating a Sell signal.

Relmada Therapeutics (RLMD) Technical Indicators

Aug 13, 2026, 11:20 PM
Name
Value
Implied Action
RSI (14)
34.80
Neutral
STOCH (9,6)
14.42
Buy
STOCHRSI (14)
14.42
Buy
MACD (12,26)
-0.35
Buy
ADX (14)
39.30
Neutral
Williams %R
-69.80
Buy
CCI (14)
-164.93
Buy
ATR (14)
0.37
-
Ultimate Oscillator
38.46
Neutral
ROC
-9.23
Sell
Relmada Therapeutics Inc’s (RLMD) Relative Strength Index (RSI) is 34.80, creating a Neutral signal.
Relmada Therapeutics Inc’s (RLMD) Trend Strength Indicator (ADX) is 39.30, creating a Neutral signal.
Relmada Therapeutics Inc’s (RLMD) Commodity Channel Index (CCI) is -164.93, creating a Buy signal.
Relmada Therapeutics Inc’s (RLMD) Price Rate of Change (ROC) is -9.23, creating a Sell signal.

FAQ

Is RLMD a Buy, Hold, or Sell?
Based on RLMD’s technical indicators, RLMD is a Sell.
    What is RLMD’s RSI (14)?
    RLMD’s RSI (14) is 34.80, which suggests RLMD is a Neutral.
      What is RLMD’s MACD?
      RLMD’s MACD is -0.35, which suggests RLMD is a Buy.
        What is RLMD’s 5-day moving average?
        RLMD’s 5-day moving average is 4.81, which suggests RLMD is a Sell.
          What is RLMD’s 20-day moving average?
          RLMD 20-day moving average is 5.14, which suggests RLMD is a Sell.
            What is RLMD’s 50-day moving average?
            RLMD’s 50-day moving average is 5.93, which suggests RLMD is a Sell.
              What is RLMD’s 200-day moving average?
              RLMD’s 200-day moving average is 5.33, which suggests RLMD is a Sell.
                What is RLMD’s Williams % R (14)?
                RLMD’s Williams % R (14) is -69.80, which suggests RLMD is a Buy.
                  What is RLMD’s CCI (14)?
                  RLMD’s CCI (14) is -164.93, which suggests RLMD is a Buy.